Our pride!
World-renowned scientist from Kyrgyzstan, KRSU graduate Asel Sartbaeva received preliminary funding for the EnsiliTech biotechnology project, of which she is a co-founder and CEO, in the amount of £1.2 million. This is reported on the website companies.
The startup's goal – is to spread ensilication, an already patented technology that will allow vaccines to be kept at normal temperatures.
«Our goal is – to make the transportation of vaccines and other vital biological materials more efficient and economical, and to reduce the carbon footprint of this critical supply chain. We are very pleased to receive the support of our investors while working on this mission», – emphasized Asel Sartbaeva.
